Zobrazeno 1 - 10
of 245
pro vyhledávání: '"David W. Dempster"'
Autor:
Barbara M. Misof, Paul Roschger, Hua Zhou, Jeri W. Nieves, Mathias Bostrom, Felicia Cosman, Robert Lindsay, Klaus Klaushofer, David W. Dempster
Publikováno v:
Bone Reports, Vol 12, Iss , Pp 100253- (2020)
The influence of treatment with alendronate (ALN), teriparatide (TPTD) or concurrent treatment with both on the human bone matrix mineralization has not yet been fully elucidated. For this purpose we analyzed quadruple fluorochrome labelled transilia
Externí odkaz:
https://doaj.org/article/12da4b5886e64aa1ace6afbbd8769409
Publikováno v:
Brazilian Journal of Nephrology, Vol 37, Iss 4, Pp 490-495 (2015)
Diabetes mellitus is a common chronic metabolic disease worldwide whose prevalence has increased during the last decades. Besides its more commonly recognized complications, such as macrovascular disease, retinopathy, nephropathy and neuropathy, diab
Externí odkaz:
https://doaj.org/article/96fb3a0d71894e1495573ac73c9c13a2
Now in its fourth edition, Osteoporosis is a classic reference on this disease, comprising a tremendous wealth of knowledge in a single source not found elsewhere. Written by renowned experts in the field, this two-volume work is a must-have for acad
Autor:
Duncan C Tourolle, David W Dempster, Charles Ledoux, Daniele Boaretti, Mauricio Aguilera, Najma Saleem, Ralph Müller
Publikováno v:
JBMR Plus, Vol 5, Iss 6, Pp n/a-n/a (2021)
ABSTRACT Postmenopausal osteoporosis is a disease manifesting in degradation of bone mass and microarchitecture, leading to weakening and increased risk of fracture. Clinical trials are an essential tool for evaluating new treatments and may provide
Externí odkaz:
https://doaj.org/article/389ccf09dd1b4baa82cfa90a15c50fbf
Autor:
E. Michael Lewiecki, John P. Bilezikian, Neil Binkley, Mary L. Bouxsein, Susan V. Bukata, David W. Dempster, Matthew T. Drake, Michael R. McClung, Paul D. Miller, Elisabeth Rosenthal, Laura L. Tosi
Publikováno v:
Journal of Clinical Densitometry. 25:649-667
The 22supnd/supAnnual Santa Fe Bone Symposium (SFBS) was a hybrid meeting held August 5-6, 2022, with in-person and virtual attendees. Altogether, over 400 individuals registered, a majority of whom attended in-person, representing many states in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::521bd5fadb06fe3662e6aec809d7ba7f
https://doi.org/10.1016/j.jocd.2022.10.002
https://doi.org/10.1016/j.jocd.2022.10.002
Autor:
Delphine Farlay, Sébastien Rizzo, David W Dempster, Shuang Huang, Arkadi Chines, Jacques P Brown, Georges Boivin
Publikováno v:
Journal of Bone and Mineral Research. 37:856-864
In postmenopausal women with osteoporosis, denosumab (DMAb) therapy through 10 years resulted in significantly higher degree of mineralization of bone, with a subsequent increase from years 2-3 to year 5 and no further difference between years 5 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3f909bba7b961bbc49cb928720ed557
https://doi.org/10.1002/jbmr.4538
https://doi.org/10.1002/jbmr.4538
Autor:
Vicente F C Andrade, Victoria Zeghbi Cochenski Borba, Débora Besen, Domingos Candiota Chula, David W. Dempster, Carolina Aguiar Moreira
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 106:e3592-e3602
Context No study has yet evaluated the relationships among bone marrow adiposity (BMA), bone histomorphometry (BH), and glycemic control in premenopausal women with type 2 diabetes (T2DM). Objective We aimed to assess the effect of glycemic control o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63524006db2444b910db4393a63839bd
https://doi.org/10.1210/clinem/dgab322
https://doi.org/10.1210/clinem/dgab322
Autor:
David W. Dempster, Felicia Cosman
Publikováno v:
Current Osteoporosis Reports. 19:189-205
There are now three anabolic agents available for the treatment of postmenopausal women at high risk for fracture. The purpose of this review is to supply a rationale to aid in determining which agent should be used in which clinical settings. Studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ed81c55c3c0bed3f5cebd6e87916108
https://doi.org/10.1007/s11914-021-00663-1
https://doi.org/10.1007/s11914-021-00663-1
Autor:
Benjamin Z. Leder, Paul D. Miller, Chris Recknor, Hua Zhou, David W. Dempster, Bruce H. Mitlak, Sudhaker D Rao, Miriam Annett, Michael S. Ominsky
Publikováno v:
Journal of Bone and Mineral Research
Anabolic osteoporosis drugs improve bone mineral density by increasing bone formation. The objective of this study was to evaluate the early effects of abaloparatide on indices of bone formation and to assess the effect of abaloparatide on modeling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ccf0ef31c3c408522f5bfbe229e970
http://europepmc.org/articles/PMC8248188
http://europepmc.org/articles/PMC8248188
Autor:
Eleftherios P. Paschalis, Sonja Gamsjaeger, Klaus Klaushofer, Elizabeth Shane, Adi Cohen, Jan Stepan, Imre Pavo, Erik F. Eriksen, Kathleen A. Taylor, David W. Dempster
Publikováno v:
Bone. 162
Postmenopausal osteoporosis (PMOP) therapies are frequently evaluated by bone mineral density (BMD) gains against patients receiving placebo (calcium and vitamin D supplementation, a mild bone turnover-suppressing intervention), which is not equivale
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b565924d4d0f1cf37c12c6dcac7438c
https://pubmed.ncbi.nlm.nih.gov/35779845
https://pubmed.ncbi.nlm.nih.gov/35779845